Scientists at the VIB-UGent Center for Plant Systems Biology and VIVES University College have developed a new method to ...

CompanyOverview|NASDAQ:CLLS] Cellectis S.A. (NASDAQ: CLLS) is a clinical-stage biotechnology company focused on developing ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach ...

ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY: Seoul, South Korea Tuesday, April 22, 2025, 15:00 Hrs [IST] ToolGen, Inc.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- Global Cancer Gene Therapy Market Poised for ...

Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

A federal district court had ruled in favor of HHS, restricting Vertex's ability to provide fertility preservation services to Medicaid patients.

When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...

Swim Across America Grants $900,000 Toward First-of-Its-Kind Gene Editing Innovation. Two doctors will look to use this grant.